These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 1872865

  • 1. Identification of a soluble enzyme from C3H/10T1/2 cells which is inhibited by the Bowman-Birk proteinase inhibitor.
    Fagan JM, Waxman L.
    Biochem Biophys Res Commun; 1991 Aug 15; 178(3):856-61. PubMed ID: 1872865
    [Abstract] [Full Text] [Related]

  • 2. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor.
    Billings PC, Habres JM, Liao DC, Tuttle SW.
    Cancer Res; 1991 Oct 15; 51(20):5539-43. PubMed ID: 1913672
    [Abstract] [Full Text] [Related]

  • 3. A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor.
    Billings PC, Habres JM.
    Proc Natl Acad Sci U S A; 1992 Apr 01; 89(7):3120-4. PubMed ID: 1557421
    [Abstract] [Full Text] [Related]

  • 4. A serine protease activity in C3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors.
    Billings PC, Carew JA, Keller-McGandy CE, Goldberg AL, Kennedy AR.
    Proc Natl Acad Sci U S A; 1987 Jul 01; 84(14):4801-5. PubMed ID: 3299374
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor.
    St Clair WH.
    Carcinogenesis; 1991 May 01; 12(5):935-7. PubMed ID: 2029760
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiapoptotic activity of the Bowman-Birk inhibitor can be attributed to copurified phospholipids.
    Foehr MW, Tomei LD, Goddard JG, Pemberton PA, Bathurst IC.
    Nutr Cancer; 1999 May 01; 34(2):199-205. PubMed ID: 10578488
    [Abstract] [Full Text] [Related]

  • 9. Proteinase inhibition using small Bowman-Birk-type structures.
    Fernandez JH, Mello MO, Galgaro L, Tanaka AS, Silva-Filho MC, Neshich G.
    Genet Mol Res; 2007 Oct 05; 6(4):846-58. PubMed ID: 18058707
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Inhibition of cathepsin G and elastase from human granulocytes by multiple forms of the Bowman-Birk type of soy inhibitor].
    Larionova NI, Gladysheva IP, Tikhonova TV, Kazanskaia NF.
    Biokhimiia; 1993 Aug 05; 58(9):1437-44. PubMed ID: 8218567
    [Abstract] [Full Text] [Related]

  • 18. A rapid purification method for soybean Bowman-Birk protease inhibitor using hydrophobic-interaction chromatography.
    Yeboah NA, Arahira M, Udaka K, Fukazawa C.
    Protein Expr Purif; 1996 May 05; 7(3):309-14. PubMed ID: 8860657
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The biochemical and functional food properties of the bowman-birk inhibitor.
    Losso JN.
    Crit Rev Food Sci Nutr; 2008 Jan 05; 48(1):94-118. PubMed ID: 18274967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.